End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.01 EUR | -.--% | -.--% | -.--% |
2021 | Ovoca Bio : Enrolls First Patient in Phase 2 Trial for Hypoactive Sexual Desire Disorder Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+7.52% | 11TCr | |
+11.38% | 11TCr | |
-12.64% | 2.22TCr | |
+0.44% | 2.23TCr | |
-4.18% | 1.94TCr | |
-37.85% | 1.79TCr | |
-8.58% | 1.72TCr | |
+37.41% | 1.25TCr | |
-23.95% | 834.13Cr |
- Stock Market
- Equities
- OVXA Stock
- OVXA Stock
- News Ovoca Bio plc
- Ovoca Bio Up 43% After Russia Approves Orenetide